|
Medical News Primary HIV-1 Infection in African Children Infected Through BreastfeedingDecember 30, 2002 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! Little is known about primary HIV infection (PHI) in children. In industrialized countries, infants are infected in utero or perinatally, making it difficult to assess the clinical picture of an acute illness associated with HIV seroconversion. However, in sub-Saharan Africa, where more than 90 percent of infected children are living, about one-third of all transmissions are postnatal (PT), resulting from breastfeeding. The current study compares clinical features in children infected postnatally by breastfeeding and in uninfected children born to HIV seropositive mothers participating in the ANRS 049 DITRAME project on the prevention of mother-to-child transmission (MTCT) performed in 1995-1998 in Cote d'Ivoire. The authors' goals were to estimate the frequency of acute retroviral syndrome (ARS) associated with pediatric HIV-1 infection, and to describe its symptomatology and associated viral parameters. Researchers used a matched case-control study retrospectively within the ANRS 049 DITRAME project. Cases were children infected postnatally through breastfeeding, all of whom were negative by at least 45 days of age, but positive on a subsequent DNA PCR sample. Clinical signs and symptoms occurring between the last negative HIV-1 DNA PCR test and the first positive test were compared to signs and symptoms observed and recorded for uninfected children during the same time period of life. For example, a case infected between three and six months was compared with two controls from three to six months of age. The authors stated that, to their knowledge, their study is the first one to examine the occurrence of ARS in African children infected through breastfeeding. They mentioned limitations to the study: the lack of information on both the duration of the clinical signs associated with PHI and the rate of progression to AIDS according to the occurrence of ARS; the fact that concomitant CD4 cell count measurements are missing; the fact that the HIV-1 RNA decrease over time may reflect a selection bias considering the declining number of samples tested during follow-up. "However," the researchers concluded, "our retrospective survey provides meaningful information on clinical and virological features associated with PHI in African children infected by breastfeeding. This emphasizes the urgent need to implement alternatives to predominant breastfeeding in order to prevent the high risk of HIV-1 PT observed in African cohorts." Furthermore, the authors suggested the findings could also be useful to identify early cases of PT and encourage adequate HIV screening in corresponding mothers and families. They pointed out that combination antiretroviral therapy during PHI reduces progression to AIDS, and "given the current content of increasing access of antiretroviral drugs in Africa, our study may also be useful to propose effective antiretroviral treatment to control the early viral replication observed in this frequent form of pediatric HIV infection." Back to other CDC news for December 30, 2002 AIDS 11.22.02; Vol. 16: P. 2303-2309; François Rouet; Narcisse Elenga; Philippe Msellati; Crépin Montcho; Ida Viho; Charlotte Sakarovitch; Christine Danel; Christine Rouzioux; Valériane Leroy; François Dabis, for the ANRS 049 Abidjan DITRAME Study Group A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
|